SEC Filings

SEC Filings

Filing date	Description	Form	View
Oct 11, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-734806.pdf 0001193125-16-734806.rtf 0001193125-16-734806.xls
Oct 11, 2016	Additional proxy soliciting materials - definitive	DEFA14A	View HTML 0001193125-16-734808.pdf 0001193125-16-734808.rtf 0001193125-16-734808.xls
Oct 06, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-732451.pdf 0001193125-16-732451.rtf 0001193125-16-732451.xls
Oct 05, 2016	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-16-144801.pdf 0001209191-16-144801.rtf
Oct 05, 2016	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0000904454-16-001476.pdf 0000904454-16-001476.rtf 0000904454-16-001476.xls
Oct 05, 2016	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0000904454-16-001478.pdf 0000904454-16-001478.rtf 0000904454-16-001478.xls
Oct 05, 2016	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0000904454-16-001480.pdf 0000904454-16-001480.rtf 0000904454-16-001480.xls
Oct 05, 2016	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-16-145046.pdf 0001209191-16-145046.rtf 0001209191-16-145046.xls
Oct 05, 2016	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-16-145048.pdf 0001209191-16-145048.rtf 0001209191-16-145048.xls
Oct 05, 2016	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-16-145049.pdf 0001209191-16-145049.rtf 0001209191-16-145049.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE